Sen­ate Fi­nance chair goes af­ter Am­gen again on US tax­es, ask­ing for pay­ment specifics

Sen­ate Fi­nance Chair Ron Wyden is ask­ing Am­gen again for more in­for­ma­tion on its fi­nan­cials as he con­tin­ues to dig in­to the way phar­ma com­pa­nies use sub­sidiaries in low- or ze­ro-tax coun­tries to low­er their bills.

The De­mo­c­rat sen­a­tor from Ore­gon said to­day that he sent Am­gen a fi­nal re­quest for “vol­un­tary com­pli­ance” to pro­vide spe­cif­ic in­for­ma­tion on Am­gen’s fi­nan­cials. The let­ter, ad­dressed to Am­gen CEO Robert Brad­way, asked him to ex­plain how Am­gen paid a low­er tax rate than the stan­dard cor­po­rate tax rate in the US of 21%.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER